Recorded Chinese product: 卡比马唑片卡比马唑片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司
主要成分Active Ingredients
- 卡比马唑Kabi Mazuo
药物知识说明
卡比马唑是一种在国家药监局注册认定的药品。标注生产企业为天津天药药业股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司、天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司、天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 卡比马唑片) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 天津天药药业股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司, 天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司, 天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 卡比马唑片Recorded Chinese product: 卡比马唑片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 5mg5 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 天津天药药业股份有限公司Chinese legal name: 天津天药药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H12020701
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H12020701
Manufacturer
Chinese legal name: 天津天药药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H12020701
生产企业
天津天药药业股份有限公司(国产)
适应症
适用于各种类型的甲状腺功能亢进症，尤其适用于：|①病情较轻，甲状腺轻至中度肿大患者；|②青少年及儿童、老年患者；|③甲状腺手术后复发，又不适于用放射性131I治疗者；|④手术前准备；⑤作为131I放疗的辅助治疗。
用法用量
1??成人。开始剂量一般为一日30mg（6片），可按病情轻重调节为15～40mg（3～8片），一日最大量60mg（12片），分次口服；病情控制后，逐渐减量，每日维持量按病情需要介于5～15mg（1～3片），疗程一般18～24个月。
2??小儿。开始时用量为每日按体重0.4mg/kg，分次口服。维持量按病情决定。
不良反应
较多见皮疹或皮肤瘙痒及白细胞减少；较少见严重的粒细胞缺乏症；可能出现再生障碍性贫血；还可能致味觉减退、恶心、呕吐、上腹部不适、关节痛、头晕头痛、脉管炎、红斑狼疮样综合征。罕致肝炎、间质性肺炎、肾炎和累及肾脏的血管炎，少见致血小板减少、凝血酶原减少或因子Ⅶ减少。
禁忌
哺乳期妇女禁用。
注意事项
1.服药期间宜定期检查血象。|2.孕妇、肝功能异常、外周血白细胞数偏低者应慎用。|3.对诊断的干扰：甲巯咪唑可使凝血酶原时间延长，并使血清碱性磷酸酶、门冬氨酸氨基转移酶（AST）和丙氨酸氨基转移酶（ALT）增高。还可能引起血胆红素及血乳酸脱氢酶升高。
贮藏
遮光，密封保存。
规格
5mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.